Literature DB >> 16919512

Dietary omega-3 fatty acid intake and cardiovascular risk.

Tricia L Psota1, Sarah K Gebauer, Penny Kris-Etherton.   

Abstract

Dietary omega-3 fatty acids decrease the risk of cardiovascular disease (CVD). Both epidemiologic and interventional studies have demonstrated beneficial effects of omega-3 fatty acids on many CVD end points, including all CVD (defined as all coronary artery disease [CAD], fatal and nonfatal myocardial infarction [MI], and stroke combined), all CAD, fatal and nonfatal MI, stroke, sudden cardiac death, and all-cause mortality. Much of the evidence comes from studies with fish oil and fish; to a lesser extent, data relate to plant-derived omega-3 fatty acids. Cardioprotective benefits have been observed with daily consumption of as little as 25 to 57 g (approximately 1 to 2 oz) of fish high in omega-3 fatty acids, an intake equivalent to >or=1 fish meal weekly or even monthly, with greater intakes decreasing risk further in a dose-dependent manner, up to about 5 servings per week. Fish, including farm-raised fish and their wild counterparts, are the major dietary sources of the longer-chain omega-3 fatty acids. Sources of plant-derived omega-3 fatty acids include flaxseed, flaxseed oil, walnuts, canola oil, and soybean oil. Because of the remarkable cardioprotective effects of omega-3 fatty acids, consumption of food sources that provide omega-3 fatty acids--especially the longer-chain fatty acids (>or=20 carbons) from marine sources--should be increased in the diet to decrease CVD risk significantly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919512     DOI: 10.1016/j.amjcard.2005.12.022

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  50 in total

Review 1.  DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.

Authors:  Yonggang Ma; Merry L Lindsey; Ganesh V Halade
Journal:  Expert Opin Drug Discov       Date:  2012-06-24       Impact factor: 6.098

Review 2.  Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.

Authors:  Akintunde O Akinkuolie; Julius S Ngwa; James B Meigs; Luc Djoussé
Journal:  Clin Nutr       Date:  2011-09-29       Impact factor: 7.324

Review 3.  Optimizing management of metabolic syndrome to reduce risk: focus on life-style.

Authors:  Cristina Bianchi; Giuseppe Penno; Giuseppe Daniele; Luca Benzi; Stefano Del Prato; Roberto Miccoli
Journal:  Intern Emerg Med       Date:  2008-02-13       Impact factor: 3.397

4.  The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation.

Authors:  Lei Wang; Eun-Jin Lim; Michal Toborek; Bernhard Hennig
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

5.  Fish oil rich in eicosapentaenoic acid protects against oxidative stress-related renal dysfunction induced by TCDD in Wistar rats.

Authors:  Kalai Selvi Palaniswamy; Vijaya Padma Vishwanadha; Saranya Ramalingam Singaravelu
Journal:  Cell Stress Chaperones       Date:  2013-10-11       Impact factor: 3.667

6.  Insights into the function of n-3 PUFAs in fat-1 transgenic cattle.

Authors:  Xin-Feng Liu; Zhu-Ying Wei; Chun-Ling Bai; Xiang-Bin Ding; Xin Li; Guang-Hua Su; Lei Cheng; Li Zhang; Hong Guo; Guang-Peng Li
Journal:  J Lipid Res       Date:  2017-06-16       Impact factor: 5.922

7.  Changing ratios of omega-6 to omega-3 fatty acids can differentially modulate polychlorinated biphenyl toxicity in endothelial cells.

Authors:  Lei Wang; Gudrun Reiterer; Michal Toborek; Bernhard Hennig
Journal:  Chem Biol Interact       Date:  2007-11-19       Impact factor: 5.192

8.  Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice.

Authors:  Phillip J White; Makoto Arita; Ryo Taguchi; Jing X Kang; André Marette
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

Review 9.  Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia.

Authors:  Sheridan M Hoy; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 10.  Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.

Authors:  Philip Barter; Henry N Ginsberg
Journal:  Am J Cardiol       Date:  2008-07-31       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.